TBVI provides technical support for product and clinical development to its partners through its Product Advancement eXperts (PAX). The PAX advises and guides vaccine researchers and developers in TBVI’s R&D network while they move their candidates from concept to clinical development. The PAX supports the definition of a final target product profile (TPP) and the development of subsequent plans for product development, characterization and clinical testing. In addition, the PAX provides technical advice to relevant stakeholders.
info@tbvi.eu
+31 (0) 6 1099 5196
Runderweg 6
8219 PK Lelystad